Investigational Drugs List
Groups Distribution
Phase Distribution
Filter Conditions
Investigational Drugs List
| Drugs ID | CID | Drugs | Identifier | Molecular Formula | Molecular Weight | Groups | US Approved | Details |
|---|---|---|---|---|---|---|---|---|
| Drug171 | 132042903 | SAR441566 | NCT06867094 | C27H24F2N6O2 | 502.50 | NULL | NULL | Details |
| Drug172 | 132123624 | BMS-986251 | NCT03329885 | C30H29F8NO5S | 667.60 | NULL | NULL | Details |
| Drug173 | 134821691 | Deucravacitinib | NCT03934216, NCT04613518, NCT03599622, NCT03262727, NCT03254784, NCT04877990 | C20H22N8O3 | 425.50 | NULL | YES | Details |
| Drug174 | 135398570 | Cyclic GMP | NCT01534312 | C10H12N5O7P | 345.21 | experimental | NO | Details |
| Drug175 | 135401907 | Allopurinol | NCT03101800 | C5H4N4O | 136.11 | approved | YES | Details |
| Drug176 | 135413496 | Balsalazide Disodium | NCT00486031, NCT00408174 | C17H13N3Na2O6 | 401.28 | approved|investigational | YES | Details |
| Drug177 | 135413535 | Valganciclovir | NCT00237653, NCT04064697 | C14H22N6O5 | 354.36 | approved|investigational | YES | Details |
| Drug178 | 135565341 | Dersalazine sodium | NCT00808977 | C35H31N6NaO4 | 622.60 | NULL | NULL | Details |
| Drug179 | 137355584 | Hemay005 | NCT05486104 | C20H22N2O7S2 | 466.50 | NULL | NULL | Details |
| Drug180 | 137441492 | Zasocitinib | NCT06254950, NCT06233461, NCT06764615 | C23H24N8O3 | 460.50 | NULL | NULL | Details |